HeartFlow
HeartFlow offers a non-invasive cardiac test called HeartFlow Analysis, which uses advanced technology to create personalized 3D models of coronary arteries, aiding in the diagnosis and management of coronary artery disease.
Services
HeartFlow offers a non-invasive personalized cardiac test that provides a detailed visualization of coronary arteries to aid in the diagnosis and management of coronary artery disease. The HeartFlow Analysis combines anatomic and physiologic data, helping physicians make informed decisions about patient care. The company also provides educational resources and support for healthcare professionals to integrate HeartFlow Analysis into clinical practice.
Products
HeartFlow's product range includes several advanced tools for cardiac assessment. The flagship product is HeartFlow FFRCT Analysis, which creates a personalized 3D model of a patient's coronary arteries from standard CT scans. Other products include HeartFlow Planner for planning treatment strategies, RoadMap Analysis for providing further insights, and Plaque Analysis for evaluating coronary plaque. These products are designed to enhance the accuracy and efficiency of coronary artery disease diagnosis and management.
Technology
HeartFlow utilizes advanced technology to create personalized 3D models of a patient's coronary arteries. By leveraging standard CT scans, HeartFlow Analysis provides detailed anatomical and physiological data, helping physicians assess coronary artery disease more precisely. The technology is grounded in rigorous research, with over 500 peer-reviewed publications supporting its effectiveness. This innovative approach facilitates better clinical outcomes through non-invasive methods.
Global Reach
HeartFlow Analysis has received FDA clearance in the United States and is also commercially available in Europe, Japan, and Canada. The global availability of HeartFlow's products underscores their commitment to improving cardiac care worldwide. By providing a standardized approach to coronary artery disease diagnosis and management, HeartFlow is actively contributing to better healthcare outcomes across various regions.
Clinical Trials
HeartFlow participates in major clinical trials to evaluate the effectiveness of its technology in clinical settings. A notable example is the PRECISE Trial, designed to assess the real-world impact of HeartFlow Analysis. Engaging in such trials helps HeartFlow validate its products and gather critical data to further refine its solutions, ensuring they meet the highest standards of clinical efficacy.